Get to know about the newly FDA-approved allergy shot, which is a cheaper version of the EpiPen.
The defect is characterized by a malfunctioning part -- called the auto-injector -- that doesn't activate when in use. Other times the device needs added force to activate.
EpiPen competitor will release the Auvi-Q on Feb.14 at a price of $4,500. This includes two talking epinephrine auto-injectors and a program called Auvi-Q Affordability.
CVS will make its generic epinephrine auto-injector available at a lower price - 83 percent cheaper than the controversial EpiPen.
It seems that EpiPen prices are not the only thing that has seen a raise in Mylan, as executives’ salaries have also seen an upward trend.